Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (Weighted Average) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $22.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 0.83% to $22.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.6 million through Dec 2025, up 0.83% year-over-year, with the annual reading at $22.6 million for FY2025, 0.83% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $22.6 million at Lemaitre Vascular, roughly flat from $22.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $22.7 million in Q3 2025, with the low at $20.5 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $22.0 million, with a median of $22.2 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) increased 6.76% in 2022, then rose 0.8% in 2023.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $21.2 million in 2021, then rose by 3.87% to $22.0 million in 2022, then increased by 1.1% to $22.2 million in 2023, then grew by 1.06% to $22.5 million in 2024, then increased by 0.83% to $22.6 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $22.6 million, $22.7 million, and $22.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.